You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 14, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Martin Tik1, Maria Vasileiadi2, Michael Woletz2
1MR Center of Excellence, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Lazarettgasse 14, Vienna 1090, Austria; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.
Investigating transcranial magnetic stimulation (TMS) dose-response in the dorsolateral prefrontal cortex (DLPFC) revealed significant individual variability. Concurrent TMS/fMRI may optimize treatment by personalizing stimulation intensity for conditions like depression.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: